Provided by Tiger Fintech (Singapore) Pte. Ltd.

AzurRx Biopharma Inc.

3.45
+0.0000
Volume:- -
Turnover:2.20M
Market Cap:34.33M
PE:-0.22
High:3.45
Open:3.45
Low:3.45
Close:3.45
Loading ...

BRIEF-AzurRx Biopharma To Report Topline Data From Phase 2B Option 2 Clinical Trial Of MS1819 In Cystic Fibrosis

Reuters
·
01 Apr 2021

AzurRx BioPharma to Report Topline Data from Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis

GlobeNewswire
·
01 Apr 2021

BRIEF-Azurrx Biopharma Completes Enrollment In Trial Of Ms1819 To Treat Cystic Fibrosis Patients With Severe Exocrine Pancreatic Insufficiency

Reuters
·
22 Mar 2021

AzurRx BioPharma Announces Completion of Enrollment in Phase 2 Clinical Trial of MS1819 in Combination with PERT in the Treatment of Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

GlobeNewswire
·
22 Mar 2021

BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Upcoming Phase 2b Clinical Trial of Cystic Fibrosis Treatment

StreetInsider
·
17 Mar 2021

BRIEF-Azurrx Biopharma Announces Completion Of Enrollment In Phase 2B Option 2 Clinical Trial Of Ms1819 In Cystic Fibrosis

Reuters
·
16 Mar 2021

AzurRx BioPharma Announces Completion of Enrollment in Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis

GlobeNewswire
·
16 Mar 2021

AzurRx BioPharma to Present at the Maxim Group Emerging Growth Virtual Conference (March 17-18)

GlobeNewswire
·
10 Mar 2021

BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Plans to Participate in 33rd Annual ROTH Conference, $10M Registered Direct Offering

StreetInsider
·
09 Mar 2021

AzurRx BioPharma Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire
·
08 Mar 2021

AzurRx BioPharma to Participate in the 33rd Annual Roth Conference

GlobeNewswire
·
08 Mar 2021

AzurRx BioPharma to Participate in “Fireside Chat” at the H.C. Wainwright Global Life Sciences Conference

GlobeNewswire
·
02 Mar 2021

BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Appoints New Chairman of the Board

StreetInsider
·
24 Feb 2021

BRIEF-Azurrx Biopharma Appoints President And CEO James Sapirstein As New Chairman Of The Board Of Directors

Reuters
·
24 Feb 2021

AzurRx BioPharma Appoints President and CEO James Sapirstein as New Chairman of the Board of Directors

GlobeNewswire
·
24 Feb 2021

InvestorNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Microcap Rodeo Winter Wonderland Conference

StreetInsider
·
17 Feb 2021

AzurRx BioPharma to Present at The Microcap Rodeo Winter Wonderland Conference

GlobeNewswire
·
16 Feb 2021

BRIEF-Azurrx Biopharma Engages Ppd To Manage Clinical Trial For Niclosamide As Treatment For Covid-19 Gastrointestinal Infections

Reuters
·
09 Feb 2021

AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections

GlobeNewswire
·
09 Feb 2021

AzurRx BioPharma to Present at BIO CEO & Investor Digital Conference

GlobeNewswire
·
08 Feb 2021